Fluorescence Angiography-assisted Management of Recurrences in Aggressive Posterior Retinopathy of Prematurity (APROP) after Intravitreal Monotherapy with 0.312 mg Bevacizumab
Klinische Monatsblatter fur Augenheilkunde, 2020-12, Vol.237 (12), p.1468 [Peer Reviewed Journal]Thieme. All rights reserved. ;EISSN: 1439-3999 ;DOI: 10.1055/a-1012-1999 ;PMID: 31770787
Digital Resources/Online E-Resources